Connect with us

Cannabis News

Whoever Legalizes Weed Wins the Presidency?

Published

on


biden trump on marijuana votes democrats file legalizatio

Cannabis.net covered how voters are looking at marijuana legalization as a key element of who they vote for in a story titled, “I Vote with My Bong“. Data shows voters are more interested in marijuana politics than party lines when it comes the great green plant. Both policitcal parties are starting to take notice as poll numbers tighten up heaading into November.

Senate Democrats have reintroduced expansive legislation aimed at legalizing cannabis at the federal level. This marks a significant policy departure, backed by broad public support. However, this year’s passage seems improbable given the upcoming November elections and the current state of divided government.

 

The Democratic platform for federal cannabis laws is fully represented by the proposed bill. By removing marijuana from the list of banned substances, where it is now ranked as one of the most dangerous and addictive drugs, its main goal is to end the federal restriction on the drug.

 

The legislation’s main features include creating a new legal framework for cannabis, imposing taxes on the expanding cannabis business, expunging certain federal marijuana-related offenses from people’s criminal histories, increasing research on the health effects of marijuana, and allocating federal funds to support people and communities harmed by the war on drugs.

 

Senate Democrats Reintroduce Expansive Cannabis Legalization Bill

 

The initiative, initially introduced in 2022, was spearheaded by Senators Chuck Schumer of New York, serving as the majority leader; Ron Wyden of Oregon, chairing the Finance Committee; and Cory Booker of New Jersey. Additionally, fifteen other Senate Democrats have lent their support as co-sponsors.

 

“On Wednesday, while addressing the Senate floor, Mr Schumer, the first majority leader to advocate for federal legalization, emphasized the detrimental impact of the nation’s failed war on drugs, particularly on communities of color. He underscored the necessity of replacing this failed approach with a more equitable, sensible, and responsible cannabis regulation framework,” the text reads.

 

The reintroduction of the bill occurred just a day after the Justice Department proposed relaxing restrictions on cannabis and downgrading its classification on the controlled substances list. While this move did not meet the demands of some advocates and numerous Democrats, it indicated a significant shift in the Biden administration’s stance toward marijuana policy liberalization.

 

“Reclassification of cannabis is undoubtedly overdue, yet it represents only a partial solution,” remarked Mr Schumer. “Congress must acknowledge the evolving landscape and heed the call of the majority of Americans for cannabis reform. It’s time for legislative action to align with public sentiment and scientific evidence.”

 

Despite the backing from prominent Democrats, the likelihood of the legislation advancing in Congress during an election year remains slim. With Republicans, many of whom oppose federal cannabis legalization, controlling the House and none endorsing the bill, its prospects are further dimmed. Congressional functions have been hindered by deep internal divisions within the Republican majority in the House. With few imperative bills remaining, proponents find limited opportunities to incorporate them into broader legislative agendas.

 

Opposition Voices Concerns Over Potential Commercialization of Legalized Marijuana

 

Former Obama, Bush, and Clinton administration drug policy advisor Kevin Sabet issued a warning about the dangers of legalization. He contended that the legalization of marijuana will cause the sector to become more commercialized, drawing comparisons to the rise of “Big Tobacco 2.0.”

 

As the current president of Smart Approaches to Marijuana, an anti-legalization advocacy group, Sabet urged against the commercialization of marijuana in the name of social justice. While acknowledging certain positive aspects of the bill, such as the expungement of criminal records and the removal of penalties for marijuana use, he stressed that legalization would essentially amplify the presence of a commercial industry.

 

“We must carefully consider the ramifications, especially in light of our detrimental experience with Big Tobacco,” he remarked. “We need to question whether this would truly be beneficial for our society.”

 

However, despite opposition from figures like Sabet, the legislation mirrors a growing trend of support among Democrats and across the nation, transcending political divides in both Republican and Democratic-leaning states. This support for legalizing access to marijuana holds significant political value, particularly in anticipation of an expected election rematch between President Biden and former President Donald J. Trump.

 

There is broad support across the country for legalizing in one way or another; according to a January Pew Research Center study, 88% of Americans think marijuana should be allowed for either medicinal or recreational use. At the moment, adult recreational use of small amounts of marijuana is permitted in 24 states, while 38 states have approved its use for medical purposes. Furthermore, legalization of marijuana has often garnered broad support on state ballots whenever it has been advocated, frequently outperforming the popularity of politicians from either party.

 

Proponents of legalization have stressed the significance of the issue as a political one and asked policymakers to consider it.

 

“Political dynamics are such that politicians are finding it more and more difficult to obstruct cannabis policy reform,” stated Morgan Fox, political director of the National Organization for the Reform of Marijuana Laws. “This issue serves as a rallying point for those advocating cannabis policy reform.”

 

Political Dynamics Surrounding Cannabis Legalization in the Biden Administration

 

The Biden administration has been pushed to completely embrace legalization and include it more prominently into President Biden’s reelection campaign by Representative Earl Blumenauer of Oregon, a well-known proponent of cannabis legalization inside Congress. According to Blumenauer, the president should be able to better connect with young people on this topic. Although their support has been erratic, they could be crucial to the outcome in November.

 

The president’s shifting position on cannabis is reflected in the Biden administration’s decision to reduce it on the list of prohibited narcotics. Thousands of people convicted of minor drug charges have received pardons from President Biden as part of his attempts to remedy racial imbalances in the criminal justice system. President Biden’s position has been reiterated by White House Press Secretary Karine Jean-Pierre, who has stated that she is certain that no one should be imprisoned or prosecuted for the simple reason of consuming or having marijuana.

 

Former President Trump’s position on legalization is more nuanced. In 2018, his administration authorized prosecutors to rigorously enforce federal marijuana restrictions in states that had relaxed their prohibitions. However, Trump later hinted at support for legislative proposals delegating legalization decisions to individual states, and he granted pardons to several nonviolent drug offenders.

 

Morgan Fox noted, “The topic of cannabis hasn’t been a prominent feature in conversations, rallies, or media appearances. It remains uncertain how a potential future Trump administration would approach cannabis policy.”

 

Congress is currently deliberating on more incremental measures aimed at loosening restrictions on marijuana, such as granting legal cannabis businesses access to financial services. While some of these bills enjoy bipartisan support, the majority are unlikely to progress in the current Congress due to opposition from Republicans.

 

Bottom Line

 

While Senate Democrats push forward with a comprehensive federal cannabis legalization bill, political hurdles loom large, particularly in a divided Congress and with opposition from Republicans. Despite growing public support and shifting stances within the Biden administration, the path to nationwide cannabis reform remains uncertain amidst ongoing debates and the upcoming November elections.

 

IS WEED A VOTING ISSUE, READ ON…

VOTE ON MARIJUANA ISSUES

VOTING ON MARIJUANA POLICY AND NOT PARTY LINES SAY VOTERS!

 



Source link

Cannabis News

California Appeals Court Rejects Marijuana Grow Permit, Citing Federal Illegality

Published

on

By


In a landmark decision that highlights the tension between state and federal cannabis laws, a California appellate court ruled on October 29th that property owners can refuse to allow the transportation of cannabis across their land via easements, even when the cannabis operation is approved by local authorities.

The Second District Court of Appeal’s unanimous decision draws attention to private property rights in a context where cannabis remains federally illegal, but state law allows licensed cultivation, distribution and sale. Presiding Justice Albert Gilbert stated, “No matter how much California voters and the Legislature might try, cannabis cultivation and transportation are illegal in California as long as it remains illegal under federal law.” JCCrandall LLC v. County of Santa Barbara, Case No. B333201, 2024 WL 4599304, Oct. 29, 2024.

Unless the California Supreme Court grants review – which I would not rule out – the decision empowers private property owners to refuse to contract with cannabis businesses, and restricts local government from approving cannabis operations that implicate the property rights of neighbors who object.

The case at hand

The dispute centered around a cannabis cultivation operation in Santa Barbara County, where JCCrandall LLC challenged a conditional use permit granted by the County to its neighbor, Santa Rita Holdings Inc. The critical issue was that Santa Rita Holdings could only access its 2.5-acre cannabis farm via an unpaved road crossing JCCrandall’s property through a pre-existing easement. JCCrandall grows oats and barley.

JCCrandall’s primary concern? It raised a number of complaints with the Santa Barbara County Supervisors about truck traffic and night operations, which did not gain traction, but in the Court of Appeal JCCrandall focused on what it claimed was potential liability associated with having federally illegal substances transported across its property, even though County regulators found that the Santa Rita operation was fully compliant with state and local laws.

Key legal findings

The appellate court’s decision hinged on several crucial points:

  1. Property Rights: The court emphasized that “the right to exclude others is the essence of the right of property ownership” and classified it as a fundamental vested right.
  2. Federal Supremacy: The panel determined that allowing cannabis transportation across private property “defies the Supremacy Clause” of the U.S. Constitution.
  3. State vs. Federal Law: While cannabis might be legal under California law, the court ruled that federal law’s prohibition takes precedence in this context.

California cannabis industry implications

Legal experts suggest this ruling could have far-reaching consequences for California’s cannabis industry. Section 1550.5(b) of the California Civil Code makes contracts within California involving cannabis lawful and enforceable, and Santa Rita Holdings bet the ranch on that argument. But the Court of Appeal held that the statute could not compel a landowner to allow cannabis to travel across its property on a pre-existing easement. Licensed operators may find it harder to do business because neighbors who have property rights affected by a cannabis business can object, and, under the JCCrandall ruling, local government must yield to those objections.

An example might be a cannabis dispensary that depends on access to its parking lot via an easement or is located in a shopping center where other lessees have rights to object to tenants notwithstanding the approval of the landlord. In cultivation, many cannabis farms depend on vehicular access through easements because they are remote and do not always have direct access to public thoroughfares, or they depend on water sourced from other properties pursuant to agreements made by prior owners who grew traditional crops. These neighbors might not need to show any negative impact on their property, but can argue that they could be found complicit in federally illegal activities.

I think the most problematic language in the JCCrandall ruling is the following, which might draw the attention of the California Supreme Court and cause it to grant review: “For as long as an easement is enjoyed, its mode and manner of use shall remain substantially the same as it was at the time the easement was created. The County argues the easement was used for agricultural purposes. But there is a vast difference between legal and illegal agricultural purposes.” (Emphasis added.) If California has determined that cannabis cultivation is legal – as it has – and state courts routinely enforce contracts involving cannabis, it is a pretty bold step to declare the use of a lawful pre-existing easement illegal simply because the agricultural crop is cannabis and take away easement access from Santa Rita.

Looking ahead

This decision creates new challenges for cannabis businesses in California, and will result in more disputes among neighbors. While the Biden administration has shown signs of easing federal marijuana restrictions, this ruling demonstrates that the federal-state law conflict continues to create significant legal hurdles for the cannabis industry.

California court decisions also can be persuasive authority in other states, so we might see similar litigation (and decisions) elsewhere in the country where cannabis has been legalized.

The case serves as a reminder that despite California’s progressive stance on cannabis, federal prohibition continues to cast a long shadow over the industry’s operations and development. As the cannabis landscape continues to evolve, this ruling may prompt businesses to reassess their property arrangements and local governments will certainly have to reconsider their permitting processes to give more careful consideration to objections by neighbors who claim that their property rights are implicated by cannabis operations.

Note: This post was first published earlier this month on the Alger ADR Blog.



Source link

Continue Reading

Cannabis News

Autoimmune Conditions Are Rising Fast in American Medicine, Can Cannabis Help?

Published

on

By


cannabis autoimmune problems

Why Are Autoimmune Conditions On The Rise? And How Cannabis Can Help

 

Autoimmune diseases refer to a group of medical conditions that occur as a result of the immune system attacking your own tissues.

 

In a normal human body, the immune system is responsible for protecting the body by producing antibodies that prevent toxins, cancer cells, and viruses from harming the body. However, when one is struck by an autoimmune disorder, the immune system is no longer able to distinguish the difference between dangerous cells and healthy cells. As a result, the healthy cells are attacked, too.

Today, we know of around 100 different kinds of autoimmune conditions. Some of the most common examples of autoimmune conditions include rheumatoid arthritis (RA), lupus, inflammatory bowel disease, celiac disease, Type 1 diabetes, multiple sclerosis (MS), and the Guillain-Barre syndrome (GBS) to name a few. Others include Graves’ disease, Hashimoto’s thyroiditis, psoriasis, and vasculitis.

 

According to the National Health Council, around 50 million Americans are affected by autoimmune diseases today. This is a conservative estimate, considering that several autoimmune conditions are tricky to treat and so many people go undiagnosed for long periods of time. It’s worrisome to note that there are more people developing autoimmune diseases these days, many of which have reached levels comparable to epidemics.

 

But cannabis can help!

 

How Cannabis Can Help Curb And Manage Autoimmune Diseases

 

Not one single cause is responsible for the alarming growth of autoimmune diseases, though there are several factors at play. While there isn’t just one cause we can point at, it’s certain the reasons lie in our environment. After all, human genetics haven’t changed significantly yet the chemicals, toxins, and pollutants in our food and everyday items have risen dramatically.

 

In addition, people are getting less sleep than ever; stress rates are through the roof, and people are constantly worried. There is a clear link between psychological stress and physical health as well as immunity, which is why it isn’t unusual – it’s even common – to see many autoimmune disease cases flare up after people experience severe stress caused by grief, an accident, job loss, or the death of a loved one. These highly stressful and traumatic conditions wreak havoc on the body’s immune response, causing inflammation all over the body.

 

Conventional treatments prescribed to treat autoimmune conditions are focused on taming inflammation; these usually include steroids but also some non-steroidal drugs. These drugs often come with unwanted side effects, but research has shown that cannabis can work with the endocannabinoid system through THC and CBD, as well as other cannabinoids, to simulate similar results. In one study for example, we can see the clear association of the endocannabinoid system for neurodegenerative and inflammatory processes seen in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.


There has also been an increasing number of studies proving the efficacy of cannabis for treating several autoimmune conditions.

 

Cannabis For Multiple Sclerosis

 

Multiple sclerosis is one of the autoimmune conditions where a growing number of studies have come out supporting the therapeutic benefits of cannabis for. In a 2024 study, patients with multiple sclerosis reported several improvements in quality of life after using cannabis-based medical products (CBMPs). For the study, British investigators analyzed the impact of cannabis based medicinal products made from either oil or extracts in 141 patients who were enrolled in the UK Medical Cannabis Registry.

 

The researchers then analyzed the changes in patient outcomes after a month, then three and 6 months after. According to the patients themselves, they were able to sustain improvements in their mental and physical health after marijuana therapy.

 

“This case series demonstrates a potential association between the initiation of CBMPs and improved patient reported outcomes in sleep, anxiety, and general HRQoL [health-related quality of life] measures, over six months,” said the study authors. “Additional measures for HRQoL, including various physical and mental health subdomains, also exhibit improvements up to six months when compared to baseline,” the authors concluded.

 

In another study from 2023, patients with multiple sclerosis reported significant improvements in symptoms after cannabis use. For the study, researchers from the Dent Neurologic Institute in Buffalo, New York, analyzed the medical records of 141 patients with multiple sclerosis, who were also legally authorized to consume medical marijuana products. They then analyzed data from the patients after one up to 4 follow-up sessions after the initial session of cannabis therapy. Sixty-five percent of patients consumed 1:1 THC:CBD tinctures.

 

According to the authors: “The results of this study indicate that use of MC [medical cannabis] to alleviate symptoms of MS is largely efficacious, with improvement in pain (72 percent of patients), muscle spasticity (48 percent of patients), and sleep disturbance (40 percent of patients) frequently reported.”

 

“More than half of opioid users at baseline were able to either discontinue or decrease their opioid use after starting MC. The mean daily MME [morphine milligram equivalents] was significantly reduced from the initial visit (51 mg) to the last follow-up visit (40 mg). This is consistent with previous literature showing that MC legalization is associated with decreased opioid use and that MC use is associated with decreased opioid use in patients with chronic pain. These findings indicate that MC may represent an alternative analgesic to opioids for some patients,” they wrote. 

 

Anecdotal Evidence

 

While more studies are needed to determine cannabis’ effect on other autoimmune conditions such as rheumatoid arthritis, we can rely on anecdotal evidence. In 2020, data from the medical journal, Rheumatology, revealed that patients who have this condition, along with those who have lupus and fibromyalgia, consume cannabis.

 

In fact, it was reported that marijuana was extremely common especially for patients with fibromyalgia. “In this meta-analysis, we found that one in six patients suffering from rheumatologic disease actively consumes cannabis, reducing pain reduction… A favorable effect of cannabis on pain in our meta-analysis reinforces the idea that cannabis could be used for analgesic purposes,” the authors concluded.

 

Conclusion

Cannabis is a safe and natural way to help prevent and treat the symptoms of autoimmune disease. It targets inflammation at its root, and is a proven natural way to help cope with stress, pain, insomnia, and inflammation all while protecting the brain. However, it’s important to ensure you medicate with clean, organic sources of marijuana.

 

AUTOIMMUNE AND CANNABIS, READ ON…

AUTOIMMUNE DISEASES THAT CANNABIS CAN HELP

CANNABIS FOR 9 DIFFERENT AUTOIMMUNE DISEASES!



Source link

Continue Reading

Cannabis News

Hemp and the New Senate Farm Bill

Published

on

By


The U.S. Senate’s version of the Farm Bill finally landed this week. They’re calling it the Rural Prosperity and Food Security Act of 2024 (the “Senate bill”). The Senate bill follows on the House’s proposal, called the Farm, Food and National Security Act of 2024 (the “House bill”), offered in May. Neither the Senate bill nor the House bill would preempt state or Indian law regarding hemp or the regulation of hemp products. This means states and tribes will retain a lot of latitude in regulating hemp and hemp-derived products– which gets people fired up.

Aside from giving states some runway, the Senate bill and the House bill differ in key respects regarding hemp. Therefore, these august bodies must confer and reconcile their sundry proposals. That could happen in 2024, but seems more likely in 2025 when the new Congress convenes. As of this week, though, we finally have a framework.

The Senate Bill re-defines “hemp” and defines “industrial hemp”

Section 10016 of the Senate bill (“Hemp Production”) amends the definition of “hemp.” Hemp was defined in the 2018 Farm Bill and removed from the federal Controlled Substances Act (CSA), taking us on a truly wild ride. See: What Happened to Hemp? (“What Happened”). The Senate bill also gives us a definition for “industrial hemp.” Here are those definitions, with points of emphasis in bold:

(1) Hemp. The term “hemp” means (A) the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 total tetrahydrocannabinol concentration (including tetrahydrocannabinolic acid) of not more than 0.3 percent on a dry weight basis; and (B) industrial hemp.

(3) Industrial Hemp. The term “industrial hemp” means the plant Cannabis sativa L. if the harvested material (A) is only (i) the stalks of that plant, fiber produced from those stalks, or any other manufactured product, derivative, mixture, or preparation of those stalks (except cannabinoid resin extracted from those stalks); (ii) whole grain, oil, cake, nut, hull, or any other compound, manufactured product, derivative, mixture, or preparation of the seeds of that plant (except cannabinoid resin extracted from the seeds of that plant); or (iii) viable seeds of that plant produced solely for production or manufacture of any material described in clause (i) or (ii); and (B) will not be used in the manufacturing or synthesis of natural or synthetic cannabinoid products.

The new regime

Again, the definitional stuff in bold is what I want to emphasize.

First, the Senate bill keeps the THC threshold at 0.3 percent, which is an arbitrary number we’ve been advocating against for years. The Senate bill mirrors the House bill in this respect, though, so we are stuck with this, unless Ron Paul gets his way.

Second, the Senate bill keeps the 2018 Farm Bill’s total THC standard, including THCA. The House bill does this too. This was fairly predictable: in What Happened, I wrote that we could “expect the total THC standard to remain, which means that actual Delta-9 THC won’t be the only metric for calculating THC content.”

We’ve also explained on this blog that the 2018 Farm Bill and USDA rules mandate total THC testing on pre-harvest hemp batches, but do not mandate such testing on post-harvest hemp or hemp products. The Senate bill doesn’t change this paradigm, which means the “loophole” for gas station weed remains open. This proposal is a big win for opponents of the House bill’s “Miller Amendment,” which would narrow the definition of “hemp” to exclude intoxicating hemp-derived substances.

Third, the Senate bill introduces a new definition and framework for industrial hemp. The House bill does this too, albeit slightly differently. The idea here is to invite farmers to grow hemp for fiber and grain purposes, while freeing them from regulatory burdens with the Department of Agriculture and criminal exposure with the Department of Justice. More specifically, for “industrial hemp” growers, the Senate bill:

  • removes background check requirements;
  • instates “relaxed regulatory requirements” for sampling and inspection methodologies (which will need to be adopted by rule); and
  • develops a certified seed program. 

The Senate bill also makes any hemp producer ineligible to grow hemp for five years if that producer, “with a culpable mental state greater than negligence, produces a crop of hemp that is inconsistent with that license.”(Hint: use the seed program.) The proof standard here seems like it could be an issue, and even if anyone has been adjudicated as growing marijuana under the guise of hemp, Farm Bill ineligibility seems like a far-off concern.

Bottom line

The big takeaway for me is that the Senate bill leaves the door open for intoxicating hemp products, whereas the Miller Amendment to the House bill does not. Something’s gotta give. And it needs to happen soon, because we’re already long overdue. As I explained in a webinar last week, the Farm Bill deals with the nation’s entire food supply, not just hemp. Therefore, this is not like with the SAFE Banking Act, where we have a proposed law specific to cannabis that may or may not ever pass. The Farm Bill must pass, and soon.

Stay tuned and we’ll keep you updated on any major happenings. For more on this topic, check out our massive hemp and CBD archive, or these specific, recent posts:



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media